Revvity opens scientific centre of excellence in Cambridge
Facility will deliver technology to scientists, helping them to translate genomic insights
Read More
Tag: Cambridge
Mission Street and BentallGreenOak to create 23-acre ‘science district’
Development will boost life sciences sector by delivering significant lab space in Cambridge
Read More
IBD research smashes recruitment target two years early
In the UK, at least 300,000 people are affected by Crohn’s disease or ulcerative colitis.
Read More
AZ’ new headquarters double in price
The initial cost of the building was estimated to be £330m.
Read More
Cancer Research and AstraZeneca launch genomics centre
Cancer Research UK and AstraZeneca have announced that they are opening a new centre in Cambridge, UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
Read More
Researchers uncover new approach for targeting p53
An alliance between industry and academia created by Cancer Research UK has discovered a new approach to targeting key cancer-linked proteins previously deemed ‘undruggable’.
Read More
Pfizer partners with Cambridge matchmaker Milner
Pfizer is the latest pharma giant to join Cambridge-based Milner Therapeutics Consortium, a global therapeutic alliance that aims to enable the transfer of materials between industry and academia.
Read More
Cambridge Uni spin-off raises £12m for cancer therapeutics
Cambridge University spin-off Storm Therapeutics has secured £12 million in series ‘A’ funding to advance its work on targeting enzymes that modify RNA to generate novel cancer therapeutics.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
